海王生物：控股子公司拟2.48亿元转让河南东森医药100%股权

Core Viewpoint - The company announced a change in market conditions leading to the decision to transfer 100% equity of Henan Dongsen to Henan Huicheng for a price of 248 million yuan [1] Group 1 - Henan Haiwang Group, a subsidiary of the company, will sign an equity transfer agreement with Henan Huicheng [1] - The transfer price for the 100% equity stake in Henan Dongsen is set at 248 million yuan [1] - Following the completion of the transfer, Henan Huicheng will fully own Henan Dongsen, and Henan Haiwang Group will no longer hold any equity in Henan Dongsen [1]